Obesity associated with increased postmenopausal invasive breast cancer risk
the ONA take:
Obesity is associated with increased risk for invasive breast cancer in postmenopausal women, a new study published online ahead of print in JAMA Oncology has shown.
For the secondary analysis, researchers sought to investigate the associations of overweight and obesity with the risk of developing postmenopausal invasive breast cancer after a long follow-up in the Women's Health Initiative studies.
Researchers analyzed data from 67,142 postmenopausal women ages 50 to 79 years. Patients were followed for a median of 13 years. During that time, 3,388 patients were diagnosed with invasive breast cancers.
Results showed that women who were overweight and obese had an increased risk for developing invasive breast cancer compared with those of normal weight. Researchers found that women with a BMI of 35.0 or higher was strongly associated with risk of developing estrogen receptor-positive and progesterone receptor-negative breast cancers.
The findings suggest that more strategies should be developed to prevent obesity in postmenopausal women.
Obesity is associated with increased risk for invasive breast cancer in postmenopausal women.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Netupitant/Palonosetron Efficacious for Prevention of N/V in Patients Receiving MEC or HEC
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|